Rezlidhia
(rez-LIH-dee-uh)
A drug used to treat adults with acute myeloid leukemia that has come back or has not gotten better with other treatment and has a mutation (change) in the IDH1 gene. It is also being studied in the treatment of other types of cancer. Rezlidhia blocks the protein made by the mutated IDH1 gene. Blocking this protein may help keep cancer cells from growing. Rezlidhia is a type of enzyme inhibitor. Also called olutasidenib.